|
Volumn 13, Issue 2, 2003, Pages 95-101
|
Gestational trophoblastic disease
|
Author keywords
Gestational trophoblastic disease; Gestational trophoblastic neoplasia; Mole; Placental site trophoblastic tumour; Staging; Treatment
|
Indexed keywords
BLEOMYCIN;
CHORIONIC GONADOTROPIN;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
HYDROXYUREA;
IFOSFAMIDE;
METHOTREXATE;
OXYTOCIC AGENT;
PACLITAXEL;
PLATINUM;
VINBLASTINE;
VINCRISTINE;
ARTIFICIAL EMBOLISM;
CANCER CLASSIFICATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER STAGING;
CHORIOCARCINOMA;
CONFERENCE PAPER;
CONTRACEPTION;
FLOW CYTOMETRY;
FOLLOW UP;
HIGH RISK POPULATION;
HUMAN;
HYDATIDIFORM MOLE;
HYSTERECTOMY;
INCIDENCE;
PATIENT REFERRAL;
PRACTICE GUIDELINE;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTOR;
TRANSVAGINAL ECHOGRAPHY;
TREATMENT OUTCOME;
TROPHOBLASTIC TUMOR;
VAGINA BLEEDING;
|
EID: 0037377913
PISSN: 09575847
EISSN: None
Source Type: Journal
DOI: 10.1054/cuog.2002.0316 Document Type: Conference Paper |
Times cited : (11)
|
References (10)
|